NCT03627169View on ClinicalTrials.gov

PSG Validation of MATRx Plus AHI

CompletedOBSERVATIONAL
Enrollment

34

Participants

Timeline

Start Date

July 25, 2017

Primary Completion Date

February 1, 2018

Study Completion Date

July 3, 2019

Conditions
Obstructive Sleep Apnea
Interventions
DEVICE

MATRx plus

The MATRx plus device will be used in its capacity as a Level III home sleep apnea test (HSAT). Note: MATRx plus is approved for use in Canada; therefore, the study does not involve any investigational devices.

Trial Locations (1)

T2H2C3

Zephyr Sleep Technologies, Calgary

All Listed Sponsors
lead

Zephyr Sleep Technologies

INDUSTRY

NCT03627169 - PSG Validation of MATRx Plus AHI | Biotech Hunter | Biotech Hunter